Physician profile
Dennis Kellar
NPI 1679683866
$11,001.11
in general payments reported to CMS, 2019-2025
36 companies · $1,918 in 2025
The $1,918 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $1,349 · 2021: $1,593 · 2022: $1,531 · 2023: $2,270 · 2024: $1,639 · 2025: $1,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,085 · Travel and Lodging: $642 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,085.14 |
| Travel and Lodging | $641.95 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,718.58 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals Lp | $1,693.69 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Inspire Medical Systems, INC. | $1,654.00 | 2020-2024 | Inspire |
| Genzyme Corporation | $1,378.05 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,376.43 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $542.00 | 2021-2025 | Dupixent |
| Electromed, INC. | $358.95 | 2021-2024 | Smartvest |
| Jazz Pharmaceuticals INC. | $313.94 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $205.68 | 2021-2023 | Opsumit |
| Philips North America LLC | $168.23 | 2020-2025 | Disposable Vest, Vest Therapy Und, (Ak6) Vest Therapy |
| Baxter Healthcare | $158.53 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Takeda Pharmaceuticals U.S.A., INC. | $157.67 | 2020-2025 | Glassia |
| Grifols USA, LLC | $140.15 | 2020-2025 | Prolastin-C Liquid |
| Insmed, INC. | $133.25 | 2021-2025 | Arikayce |
| Amgen INC. | $101.95 | 2021-2025 | Tezspire |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $96.27 | 2023 | Da Vinci Surgical System |
| Harmony Biosciences LLC | $95.34 | 2020-2022 | |
| Axsome Therapeutics, INC. | $94.26 | 2025 | Sunosi |
| Inogen, INC. | $88.20 | 2021-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen One G3 Oxygen Concentrator |
| Verona Pharma, INC. | $74.72 | 2025 | Ohtuvayre |
| Mylan Specialty L.P. | $66.65 | 2020-2023 | Yupelri |
| Mallinckrodt Hospital Products INC. | $66.61 | 2022-2023 | Acthar |
| Sunovion Pharmaceuticals INC. | $36.16 | 2020 | |
| Ethicon US, LLC | $35.63 | 2020 | |
| Shire North American Group INC | $32.11 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $31.96 | 2021 | |
| Mallinckrodt Enterprises LLC | $22.74 | 2019 | |
| Phadia US INC. | $20.34 | 2021 | |
| Apria Healthcare LLC | $20.09 | 2021 | |
| Vifor Pharma, INC. | $19.32 | 2025 | Zemaira |
| Advanced Respiratory, INC | $18.79 | 2019 | |
| Lilly USA, LLC | $18.38 | 2025 | Zepbound |
| E.R. Squibb & Sons, L.L.C. | $17.60 | 2021 | |
| Genentech USA, INC. | $17.52 | 2022 | |
| Circassia INC. | $15.00 | 2020 | |
| Ucb, INC. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Kellar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.